MYC and Miyoshi myopathy: In addition to MYC deregulation, ABBV-075 triggers G1 phase arrest and apoptosis (via the intrinsic pathway) primarily in hematological malignancies, for example, AML, non-Hodgkin lymphoma and MM cells.